In March 2025, the Health Sciences Institute in Aragon released a document that provides guidance on incorporating real-world data into health technology assessment, focusing on the preadoption phase for evaluating new technologies in the Spanish Network of HTA Agencies (RedETS) framework. It outlines a workflow aligning with RedETS practices, identifying key milestones where RWD adds value and offering methods and tools to integrate RWD into decision models.

MTRC, a leading boutique Med Tech market access consultancy in Europe, is looking for a Director of Health Economics and Outcomes Research.

MTRC, a leading boutique Med Tech market access consultancy in Europe, is looking for a Director of Market Access.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Gsteiger et al. explored the conceptual divergence between “technology assessment” and “technology appraisal” in the context of the new EU HTA Regulation. The authors advocated for a clearer distinction between scientific evaluation and value judgments to ensure effective implementation and avoid ambiguity. The study emphasized the importance of transitioning from centralized assessments to national-level appraisal processes that reflect local value judgments and uncertainties.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 24th of March, we plan to work on 20 projects. Review the complete list of planned activities in this post.

On March 6, 2025, NHS England released an annual update of the HRG4+ Local Payment Grouper for 2025/26, to come into effect on April 1, 2025. No new HRGs were added; the total number of HRGs has not changed (2,900).

MTRC is pleased to announce its membership in ABHI, the UK’s leading industry association for health technology (HealthTech). By joining ABHI, MTRC strengthens its commitment to supporting the industry with high-quality insights and strategic guidance, ensuring that companies remain at the forefront of innovation in an evolving healthcare landscape.

In January-February 2025, Health Technology Wales (HTW) accomplished one full appraisal of catheter-locking solutions to prevent catheter-related complications. No Med Tech-related Topic Exploration Reports were published.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Mermillod et al. estimated the carbon footprint of the Geneva healthcare system. The study identifies key emission contributors, highlighting medicines and medical devices as the dominant global emission sources (59%). When excluding these, hospitals emerge as the primary source of emissions (48%), followed by nursing homes and private practices. The authors outlined direct and systemic strategies for reduction, including optimizing prescription practices, energy use, and transportation. The findings provide a foundation for policymakers to implement ambitious carbon reduction policies in healthcare.

In late January 2025, the Nordic Initiative for Environmental Labelling of Medical Supplies (NIELS) project was completed. The initiative was aimed to promote greener procurement of medical equipment by expanding the use of eco-labeling. Following its successful conclusion, the project is now considering opportunities to broaden the dialogue to a European level.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Elvidge et al. introduced the CHEERS-AI checklist, a standardized reporting framework for economic evaluations of AI-based health interventions. Developed through a Delphi study with multidisciplinary experts, the checklist comprises 38 reporting items, including AI-specific considerations. By improving transparency and reproducibility, CHEERS-AI aims to enhance the quality of cost-effectiveness assessments and facilitate informed decision-making in AI-driven healthcare.

In February and March 2025, the Common Catalog of Genetic and Genomic Tests of the National Health System was updated in Spain. A new section, “Hepatic diseases,” was added, including 24 tests for multiple hepatic diseases.